Zeltzer, Ehud
Mayo Clinic
Department of Neurology, University of California, San Francisco, San Francisco, CA.
Citations 1
Amyloid PET in Sporadic Early‐ Versus Late‐Onset Alzheimer's Disease: Comparison of the LEADS and ADNI
Lagarde, Julien , Blazhenets, Ganna , Zhang, J. , Eloyan, Ani , Thangarajah, Maryanne, Taurone, Alexander, Allen, Isabel Elaine , Soleimani‐Meigooni, David N. , Zeltzer, Ehud , Windon, Charles , Raya, Maison Abu , Smith, Karen, Shankar, Ranjani , Amuiri, Alinda, Rocha, Salma, Hammers, Dustin B. , Dage, Jeffrey L. , Kirby, Kala, Aisen, Paul, Koeppe, Robert, Landau, Susan, Carrillo, María C. , Touroutoglou, Alexandra , Brickhouse, Michael , Raman, Rema , Day, Gregory S. , Duara, Ranjan, Graff‐Radford, Neill R. , Masdeu, Joseph C. , Mendez, Mario F. , Onyike, Chiadi U. , Riddle, Meghan , Grant, Ian , Rogalskı, Emily , Johnson, Erik C. B. , Salloway, Stephen , Sha, Sharon J. , Turner, Raymond Scott , Wingo, Thomas S. , Apostolova, Liana G. , Joie, Renaud La , Rabinovici, Gil D. , Blazhenets, Ganna , Soleimani-Meigooni, David , Zeltzer, Ehud , Windon, Charles , Abu Raya, Maison , Vrillon, Agathe , Nudelman, Kelly N , Vemuri, Prashanthi , Day, Gregory S , Masdeu, Joseph C , Musiek, Erik , Sha, Sharon , Wingo, Thomas S , La Joie, Renaud , Rabinovici, Gil D , Dage, Jeffrey L , Maiti, Piyush , Schonhaut, Daniel R. , Hammers, Dustin B , Nudelman, Kelly , Kirby, Kala, Vemuri, Prashanthi , Beckett, Laurel , Atri, Alireza , Honig, Lawrence S. , Jones, David T., Womack, Kyle , Wolk, David A. , Dickerson, Bradford Clark
Annals of Neurology | March 17, 2025 | Volume: 98 | Issue: 2 | Pages: 236-248
Objective Early‐onset Alzheimer's disease (EOAD) and late‐onset Alzheimer's disease (LOAD) differ in many respects. Here, we address the issue of possible differences in fibrillar amyloid pathology as measured by positron emission tomography (PET), which remains unresolved due to the lack of large‐scale comparative studies. Methods Three hundred ninety‐nine cognitively impaired participants younger than 65 years of age from the multicenter Longitudinal Early‐onset Alzheimer's Disease Study (LEADS) and 450 cognitively impaired participants older than 65 years from the Alzheimer's Disease Neuroimaging Initiative (ADNI) underwent clinical assessment, brain magnetic resonance imaging (MRI), and amyloid PET and were included in this study. We compared amyloid PET outcomes (positivity rate based on visual read and quantified tracer uptake expressed as Centiloids [CLs]) between the 2 cohorts and studied their association with age, sex, APOE genotype, and cognition. Results The amyloid positivity rate was higher in LEADS (78%, 95% confidence interval [CI] = 74–82) than in ADNI (71%, 95% CI = 67–75, p = 0.02). Lower Mini‐Mental State Examination (MMSE) and APOE4 genotype increased the odds of amyloid positivity in both cohorts. Visually positive scans had higher CLs in LEADS (EOAD, mean = 95.3 ± 26.1) than in ADNI (LOAD, mean = 80.9 ± 36.8, p < 0.0001), predominantly in parietal cortex/precuneus, superior temporal, and frontal cortices. In amyloid‐positive patients, (1) CLs were higher in female patients in both cohorts; (2) APOE4 carriership was associated with lower CLs in EOAD, which was not observed in LOAD; and (3) correlations between CLs and MMSE scores were significantly stronger in EOAD than in LOAD. Interpretation Differences in the burden of amyloid pathology may contribute to differences in clinical and anatomic patterns in sporadic EOAD and LOAD, and have implications for optimizing therapeutic strategies in each group. ANN NEUROL 2025;98:236–248